Jack Lawler
Chief Tech/Sci/R&D Officer presso CHEMOMAB THERAPEUTICS LTD.
Profilo
Jack Lawler is currently the VP-Global Clinical Development Operations at Chemomab Therapeutics Ltd.
He previously worked as the VP-Clinical Operations & Data Management at Goldfinch Bio, Inc. Mr. Lawler completed his undergraduate degree at Rosemont College.
Posizioni attive di Jack Lawler
Società | Posizione | Inizio |
---|---|---|
CHEMOMAB THERAPEUTICS LTD. | Chief Tech/Sci/R&D Officer | 04/01/2022 |
Precedenti posizioni note di Jack Lawler
Società | Posizione | Fine |
---|---|---|
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formazione di Jack Lawler
Rosemont College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
CHEMOMAB THERAPEUTICS LTD. | Health Technology |
Aziende private | 1 |
---|---|
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Jack Lawler